Recent developments in the delivery of peptide nucleic acids (PNAs)
RSC Chemical Biology · 2026 · 7 (3) · 363-375
DOI: 10.1039/d5cb00301f ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RSC Chemical Biology, 2026. Verfasst von Srijani Sarkar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Innovative Genomics Institute, University of California Berkeley Berkeley CA USA nmurthy@berkeley.edu. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
PNAs have strong therapeutic potential but poor cellular uptake. This graphic highlights approaches like backbone modification, transporter conjugation, and nanoparticle encapsulation that have improved delivery and enhanced antisense activity.
Autor:innen und Institutionen
- Department of Bioengineering, Innovative Genomics Institute, University of California Berkeley Berkeley CA USA nmurthy@berkeley.edu.
ORCID-Profile: Srijani Sarkar, Niren Murthy
Zitieren
APA
Sarkar, S., & Murthy, N. (2026). Recent developments in the delivery of peptide nucleic acids (PNAs). RSC Chemical Biology, 7(3), 363-375. https://doi.org/10.1039/d5cb00301f
Vancouver
Sarkar S, Murthy N. Recent developments in the delivery of peptide nucleic acids (PNAs). RSC Chemical Biology. 2026;7(3):363-375. doi:10.1039/d5cb00301f
BibTeX
@article{Sarkar2026,
author = {Sarkar, Srijani and Murthy, Niren},
title = {Recent developments in the delivery of peptide nucleic acids (PNAs)},
journal = {RSC Chemical Biology},
year = {2026},
volume = {7},
number = {3},
pages = {363--375},
doi = {10.1039/d5cb00301f}
}
EUVIMED